NewEdge Advisors’s Sarepta Therapeutics SRPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.35K	Hold	200	–	–	﹤0.01%	3631
2025 Q4	$4.3K	Sell	200 -4	-2%	-$84	﹤0.01%	3721
2025 Q3	$3.93K	Hold	204	–	–	﹤0.01%	3604
2025 Q2	$3.49K	Hold	204	–	–	﹤0.01%	3494
2025 Q1	$13K	Hold	204	–	–	﹤0.01%	3002
2024 Q4	$24.8K	Sell	204 -8,726	-98%	-$1.07M	﹤0.01%	2750
2024 Q3	$1.12M	Buy	8,930 +3,339	+60%	+$462K	0.01%	1050
2024 Q2	$883K	Sell	5,591 -1,363	-20%	-$175K	0.01%	1130
2024 Q1	$900K	Buy	6,954 +6,582	+1,769%	+$806K	0.01%	1048
2023 Q4	$35.9K	Buy	372 +45	+14%	+$4.32K	﹤0.01%	2335
2023 Q3	$39.6K	Hold	327	–	–	﹤0.01%	2160
2023 Q2	$37.4K	Sell	327 -8	-2%	-$1.03K	﹤0.01%	2178
2023 Q1	$46.2K	Sell	335 -11	-3%	-$1.43K	﹤0.01%	2037
2022 Q4	$45	Buy	+346	New	+$40.1K	﹤0.01%	3489
2021 Q1	–	Sell	-1,250	Closed	-$213K	–	1107
2020 Q4	$213K	Buy	+1,250	New	+$185K	0.01%	879
2020 Q3	–	Sell	-1,542	Closed	-$247K	–	974
2020 Q2	$247K	Buy	+1,542	New	+$210K	0.01%	723
2018 Q4	–	Sell	-1,369	Closed	-$221K	–	705
2018 Q3	$221K	Buy	+1,369	New	+$187K	0.02%	587